Barclays Lifts Rocket Lab Target to $138

The bank raised its price target on the space company, which is also acquiring satellite connectivity specialist Iridium Communications.

Updated on Nov. 20, 2026 in Public Companies

Photograph of a slender white launch vehicle standing on a concrete pad at dawn beneath a pale sky over a flat coastal horizon.
Barclays raised its price target on Rocket Lab to $138, as the space company moves to acquire satellite connectivity firm Iridium Communications. AI Illustration. Upload story photo >

Barclays raised its share price target for Rocket Lab to $138, equal to about €128.53. Rocket Lab was trading at $53 on November 19, according to the extraction.

Why it matters

A price target this far above the recent trading level signals analyst confidence in Rocket Lab's growth outlook. The pending Iridium acquisition adds a satellite connectivity business to the company's portfolio.

Barclays' $138 target equals €128.53, against a Rocket Lab share price of $53 on November 19. The extraction does not specify the deal value of the Iridium acquisition or when it is expected to close.

The players

Rocket Lab

Rocket Lab is a space launch and satellite company headquartered in Long Beach, California, with founding roots in New Zealand.

Barclays

Barclays is a major British multinational bank whose analysts issue price targets on publicly traded companies.

The details

Rocket Lab launched its 100th Electron rocket and is building its Neutron vehicle. The company is also acquiring satellite connectivity specialist Iridium Communications, and Barclays raised its price target on November 20.

Timeline

  1. November 19, 2026: Rocket Lab traded at $53 per share.

  2. November 20, 2026: Barclays raised its Rocket Lab price target to $138.

Market Landscape

Rocket Lab's vertical integration, covering rockets and satellites, gives it scale and cost advantages over most space-industry peers. The Iridium acquisition would push that model further into the high-margin satellite communications market.

Investors tracking Rocket Lab now have an analyst target well above the recent $53 trading level to weigh against the company's execution risk. The extraction does not describe any direct effect on customers or product pricing.

The takeaway

Analyst price targets reflect expectations rather than guarantees, so readers should compare the $138 figure with company results and deal terms as they are reported. Rocket Lab's trajectory will depend on how the Iridium deal and its Neutron program develop.

Further reading

For more on how publicly traded companies are valued by analysts, explore Public Companies.

Source note: This article includes information reported by Advanced-television.